#1 Clinical Trials Search in Europe

Bleomycin Sulfate

Bleomycin sulfate, a powerful antineoplastic drug, is being studied in various clinical trials to explore its potential in treating different medical conditions. These trials aim to evaluate the efficacy and safety of bleomycin sulfate in treating cutaneous warts, venous malformations, lymphatic malformations, and as part of combination therapies for cancers like Hodgkin’s lymphoma and Kaposi’s sarcoma. The research focuses on optimizing dosages, comparing bleomycin to other treatments, and investigating its use in combination with other drugs to improve patient outcomes.

Table of Contents

What is Bleomycin?

Bleomycin sulfate, often simply called bleomycin, is an anticancer drug derived from the bacterium Streptomycus verticillus[9]. It’s also known by other names such as Bleomycin Baxter, Zeocin, and Blenoxane[4][8]. Bleomycin works by damaging the DNA in cells, which can stop cancer cells from growing and dividing[9].

Uses of Bleomycin

Bleomycin is used to treat various conditions:

  • Cancer treatment: It’s used in the treatment of several types of cancer, including lymphoma and testicular cancer[9].
  • Vascular anomalies: Bleomycin is used to treat various types of vascular (blood vessel) abnormalities:
    • Venous malformations: These are abnormal clusters of blood vessels[4].
    • Lymphatic malformations: These are fluid-filled spaces caused by abnormal development of lymphatic vessels[8].
    • Infantile hemangiomas: These are benign (non-cancerous) growths of blood vessels that appear in infants[3].
  • Skin conditions: Bleomycin is used to treat various skin conditions:
    • Cutaneous warts: These are small, rough growths on the skin caused by a virus[2].
    • Keloid and hypertrophic scars: These are types of raised scars that can occur after injury to the skin[1].
  • Kaposi’s sarcoma: This is a type of cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and throat, or in other organs[7].

How Bleomycin is Administered

Bleomycin can be given in several ways, depending on the condition being treated:

  • Intravenous (IV) injection: The drug is injected directly into a vein. This is often used for cancer treatment[9].
  • Intralesional injection: The drug is injected directly into the abnormal tissue. This is often used for vascular malformations and skin conditions[2][8].
  • Sclerotherapy: This is a procedure where bleomycin is injected into blood vessels to shrink them. It’s often used for vascular malformations[4].
  • Electrochemotherapy: This is a technique where bleomycin is given intravenously, and then electric pulses are applied to the tumor area. This helps the bleomycin enter the cancer cells more effectively[9].

Efficacy of Bleomycin

The effectiveness of bleomycin varies depending on the condition being treated:

  • Cancer: Bleomycin has been shown to be effective against certain types of cancer, particularly when used in combination with other drugs[5].
  • Vascular malformations: Studies have shown that bleomycin can be effective in reducing the size of various types of vascular malformations[4][8].
  • Skin conditions: Bleomycin has shown promising results in treating warts and certain types of scars[2][1].

Potential Side Effects

Like all medications, bleomycin can cause side effects. Some potential side effects include:

  • Skin reactions: About half of patients may experience skin-related side effects such as redness, skin soreness, or changes in skin color[9].
  • Lung problems: In rare cases (about 1% of patients), bleomycin can cause serious lung problems, including a condition called pulmonary fibrosis[9].
  • Other side effects: These may include fever, loss of appetite, and fatigue[9].

The risk of side effects may increase with higher doses and in older patients[9].

Ongoing Research

Researchers are continually studying bleomycin to improve its use and effectiveness:

  • Dose optimization: Studies are investigating whether lower doses of bleomycin can be as effective as standard doses while reducing side effects[9].
  • Combination therapies: Researchers are studying how bleomycin works when combined with other treatments, such as dexamethasone for infantile hemangiomas[3].
  • New applications: Scientists are exploring the use of bleomycin for conditions it hasn’t traditionally been used to treat[1].

It’s important to note that while bleomycin is a powerful and useful drug, it should only be used under the close supervision of a healthcare professional. Your doctor will weigh the potential benefits against the risks for your specific situation.

Condition Trial Type Bleomycin Administration Comparison/Combination Key Outcomes Measured
Cutaneous Warts Randomized Controlled Trial Intralesional Compared to Cryotherapy Change in morphology of cutaneous warts
Venous Malformations Comparative Study Intralesional Compared to and combined with Fibrovein Pain intensity, frequency, and type
Lymphatic Malformations Dose Comparison Study Intracapsular injection Low-dose (1mg/ml) vs High-dose (2mg/ml) Changes in volume, pain score, quality of life
Cutaneous Malignancies Randomized Controlled Trial Intravenous (with Electrochemotherapy) Standard dose vs 50% reduced dose Overall response rate, aesthetic outcome, quality of life
Hemangioma Randomized Controlled Trial Intralesional Compared to Oral Propranolol Size regression, efficacy, complications
Kaposi’s Sarcoma (AIDS-related) Comparative Trial Intravenous (with Vincristine) Compared to Stealth Liposomal Doxorubicin Efficacy, safety, and tolerance
Hodgkin’s Lymphoma Phase II Study Intravenous (as part of ABVD) Combined with Rituximab 5-year failure-free survival rate

FAQ

  • What is bleomycin sulfate used for in clinical trials? Bleomycin sulfate is being studied for treating various conditions, including cutaneous warts, venous malformations, lymphatic malformations, Hodgkin's lymphoma, and Kaposi's sarcoma. It's used both as a standalone treatment and in combination with other drugs.
  • How is bleomycin administered in these trials? The administration of bleomycin varies depending on the condition being treated. It can be given intralesionally (injected directly into the affected area), intravenously, or as part of a combination therapy with other drugs.
  • Are there any side effects associated with bleomycin use? Yes, potential side effects of bleomycin include skin-related issues (such as erythema, hyperpigmentation, and soreness) and pulmonary reactions. In rare cases, it can lead to pulmonary fibrosis. The trials are designed to monitor and assess these potential side effects.
  • How does bleomycin compare to other treatments in these trials? Several trials are comparing bleomycin to other treatments. For example, one study compares intralesional bleomycin to cryotherapy for cutaneous warts, while another compares bleomycin to propranolol for hemangiomas. These comparisons help determine the most effective treatment options for different conditions.
  • What is the goal of reducing bleomycin dosage in some trials? Some trials are exploring reduced dosages of bleomycin to minimize potential side effects while maintaining efficacy. For instance, one study is investigating whether halving the standard dose of bleomycin in electrochemotherapy is equally effective as the full dose for treating cutaneous malignancies.

Ongoing Clinical Trials on Bleomycin Sulfate

  • Study on the Effectiveness of Laparoscopic Electrochemotherapy with Bleomycin Sulfate for Patients with Locally Advanced Pancreatic Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Improving Treatment for Young Adults with Poor-Prognosis Non-Seminomatous Germ-Cell Tumors Using Paclitaxel and Drug Combination

    Recruiting

    2 1 1 1
    Investigated drugs:
    France

  • Study on Electrochemotherapy with Carboplatin and Bleomycin for Women with Relapsed Vulvar Cancer After Multiple Treatments

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    Italy

  • Study on Electrochemotherapy with Bleomycin for Patients with Recurrent Oral and Oropharyngeal Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria Denmark Germany The Netherlands Norway Sweden

  • Study Comparing Brentuximab Vedotin with Drug Combination for Treating Advanced Classical Hodgkin Lymphoma in Patients

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Czechia Denmark France Hungary Italy +3

Glossary

  • Bleomycin Sulfate: An antineoplastic drug derived from Streptomyces verticillus, used to treat various types of cancer and being studied for other conditions. It works by causing DNA strand breaks in cells.
  • Cutaneous Warts: Benign skin growths caused by human papillomavirus (HPV) infection.
  • Venous Malformation: An abnormal formation of veins that can occur anywhere in the body, often present at birth.
  • Lymphatic Malformation: A rare non-malignant mass in the head or neck area resulting from abnormal formation of lymphatic vessels.
  • Electrochemotherapy: A cancer treatment that combines chemotherapy with electrical pulses to increase drug uptake into cancer cells.
  • Hemangioma: A benign tumor formed by a collection of excess blood vessels, often appearing as a red birthmark.
  • Kaposi's Sarcoma: A type of cancer that causes patches of abnormal tissue to grow under the skin, in the lining of the mouth, nose, and throat, or in other organs.
  • Hodgkin's Lymphoma: A type of cancer that affects the lymphatic system, part of the body's germ-fighting immune system.
  • ABVD: A chemotherapy regimen used to treat Hodgkin's lymphoma, consisting of Adriamycin (doxorubicin), Bleomycin, Vinblastine, and Dacarbazine.
  • Intralesional: Referring to the administration of a drug or substance directly into a lesion or affected area of the body.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.

References

  1. https://clinicaltrials.gov/study/NCT04046679
  2. https://clinicaltrials.gov/study/NCT05023408
  3. https://clinicaltrials.gov/study/NCT06080724
  4. https://clinicaltrials.gov/study/NCT01347294
  5. https://clinicaltrials.gov/study/NCT01873326
  6. https://clinicaltrials.gov/study/NCT05327309
  7. https://clinicaltrials.gov/study/NCT00002105
  8. https://clinicaltrials.gov/study/NCT06437158
  9. https://clinicaltrials.gov/study/NCT06647342